Diagnostic

Chennai-based Aarthi Scans plans to add 65 new centres by 2030, with 90% in North India, while exploring fitness diagnostics and targeting a Rs 600 crore turnover

Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. No timeline was, however, revealed for the investment rollout. "This collaboration will assist us in expanding our reach and offer high-quality diagnostic services to a large population in eastern India," Suraksha Diagnostics CMD Somnath Chatterjee said. United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres, the company said. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres an

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year

The competition watchdog CCI on Tuesday approved Fortis Healthcare's proposal to acquire an additional 31.52 per cent stake in Agilus Diagnostics. Multi-speciality hospital chain Fortis Healthcare Ltd (FHL) is engaged in providing integrated healthcare delivery services like medicare, healthcare and diagnostics. The diagnostics services business of FHL is being undertaken primarily through Agilus. "Commission approves the acquisition of additional 31.52 per cent share capital of Agilus Diagnostics Ltd by Fortis Healthcare Ltd," according to a post by CCI on X. After the transaction, the shareholding of Fortis Healthcare Ltd (FHL) in Agilus will increase from 57.68 per cent to 89.2 per cent. In August, Fortis Healthcare announced that it will acquire a 31 per cent stake in Agilus Diagnostics for Rs 1,780 crore valuing Agilus at Rs 5,700 crore. The Competition Commission of India (CCI) has also cleared the proposed merger of Diliigent Power into DB Power, and the reorganisation of

Easing of pressure from predatory pricing and steady network expansion is boosting growth for diagnostics companies, say Abdulkader Puranwala and Nisha Shetty of ICICI Securities

The projected rise in revenue comes on the back of an estimated 8% growth in FY24

The participation aims to add to the diagnostic service provider's international portfolio. Its international network consists of several centres and pick-up points (PUPs) across multiple locations

Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services

It may be possible to detect signs of Parkinson's disease 20-30 years before symptoms appear, according to researchers in Australia. A biomarker called F-AV-133, used in combination with PET, or positron emission tomography, scans can help diagnose Parkinson's disease and accurately track neurodegeneration, the researchers from the Florey Institute of Neuroscience and Mental Health, Melbourne, said. F-AV-133 is an imaging agent and has shown promise as a PET tracer for detecting and monitoring neurodegeneration in Parkinson's disease, a progressive neurological disorder characterised by tremor and impaired muscular coordination. According to the researchers, the disease, often thought of as an illness of old age, in fact, starts in midlife and can go undetected for decades. "Parkinson's disease is very hard to diagnose until symptoms are obvious, by which time up to 85 per cent of the brain's neurons that control motor coordination have been destroyed. At that point, many treatment

Dilip filed a complaint before the Delhi State Commission, alleging that the RFA procedure was carried out without his knowledge or consent, and also without considering the findings of the EPS

Med-tech companies are working round the clock to come up with AI-based solutions

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors

Promoters are focused on strengthening the Metropolis brand, although it continuously keeps exploring various strategic options/investment opportunities

Dr Lal PathLabs is India's largest diagnostic services player by revenue, with 289 laboratories across the country

Announced foray into fragmented diagnostic business where organised chains have less than 20% share of overall business

Patna police have raided a plasma diagnostic lab and seized a large number of fake RT-PCR Covid-19 reports, police said.

The company is planning to set up 10 more labs in the northern and eastern parts of the country for deeper penetration